Prognostic value of white blood cell count in acute myocardial infarction: Long-term mortality;Valor pronóstico del recuento leucocitario en el infarto agudo de miocardio: Mortalidad a largo plazo

Revista Espanola de Cardiologia

Volumn 58, Issue 6, 2005, Pages 631-639

  Núñez Villota, Julio ^a   Fácila, Lorenzo ^a   Llàcer, Àngel ^a   Sanchís, Juan ^a   Bodí, Vicent ^a   Bertomeu, Vicente ^a   Sanjuán, Rafael ^a   Blasco, María L ^a   Consuegra, Luciano ^a   Bosch, María J ^a   Chorro, Francisco J ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Acute myocardial infarction; Leukocyte count; Mortality

Indexed keywords

CREATININE; TROPONIN I;

ACUTE HEART INFARCTION; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PROGNOSIS; REGRESSION ANALYSIS; ST SEGMENT ELEVATION;

EID: 23044477315     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13076415     Document Type: Article

References (41)

1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135-43.
2. Robbins M, Topol EJ. Inflammation in acute coronary syndromes. Cleve Clin J Med. 2002;69 Suppl 2:130-42.
3. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-26.
4. Sanchís J, Bodí V, Llàcer A, Fácila L, Martínez-Brotons A, Insa L, et al. Relación de los valores de proteína C reactiva con los hallazgos angiográficos y los marcadores de necrosis en el síndrome coronario agudo sin elevación del segmento ST. Rev Esp Cardiol. 2004;57:382-7.
5. Bodí V, Sanchís J, Llácer A, Fácila L, Núñez J, Pellicer M, et al. Indicadores pronósticos del síndrome coronario agudo sin elevación del segmento ST. Rev Esp Cardiol. 2003;56:857-64.
6. Bodí V, Fácila L, Sanchís J, Llácer A, Núñez J, Mainar L, et al. Pronóstico a corto plazo de los pacientes ingresados por probable síndrome coronario agudo sin elevación del segmento ST. Papel de los nuevos marcadores de daño miocárdico y de los reactantes de fase aguda. Rev Esp Cardiol. 2002;55:823-30.
7. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med. 2000;343:1139-47.
8. Mueller C, Buettner HJ, Hodgson JM, Marsch S, Perruchoud AP, Roskamm H, et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation. 2002;105:1412-5.
9. Bodi V, Sanchís J, Llácer A, Fácila L, Núñez J, Pellicer M, et al. Valor independiente de la proteína C reactiva para predecir acontecimientos adversos al primer mes y al año en los síndromes coronarios agudos sin elevación del ST. Med Clin (Barc). 2004;122: 248-52.
10. Sanchís J, Bodí V, Llácer A, Núñez J, Fácila L, Ruiz V, et al. Usefulness of C-reactive protein and left ventricular function for risk assessment in survivors of acute myocardial infarction. Am J Cardiol. 2004;94:766-9.
11. Cooper HA, Exner DV, Waclawiw MA, Domanski MJ. White blood cell count and mortality in patients with ischemic and non-ischemic left ventricular systolic dysfunction (an analysis of the Studies Of Left Ventricular Dysfunction [SOLVD]). Am J Cardiol. 1999;84:252-7.
12. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA. Leukocytes and the risk of ischemic diseases. JAMA. 1987;257: 2318-24.
13. Bovill EG, Bild DE, Heiss G, Kuller LH, Lee MH, Rock R, et al. White blood cell counts in persons aged 65 years or more from the Cardiovascular Health Study. Correlations with baseline clinical and demographic characteristics. Am J Epidemiol. 1996;143: 1107-15.
14. Zalokar JB. Re: leukocyte counts and coronary heart disease in a japanese cohort. Am J Epidemiol. 1983;118:611-2.
15. Ensrud K, Grimm RH Jr. The white blood cell count and risk for coronary heart disease. Am Heart J. 1992;124:207-13.
16. Grimm RH Jr, Neaton JD, Ludwig W. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. JAMA. 1985;254:1932-7.
17. Lee CD, Folsom AR, Nieto FJ, Chambless LE, Shahar E, Wolfe DA. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in african-american and white men and women: atherosclerosis risk in communities study. Am J Epidemiol. 2001;154:758-64.
18. Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson CM. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation. 2000;102:2329-34.
19. Barron HV, Harr SD, Radford MJ, Wang Y, Krumholz HM. The association between white blood cell count and acute myocardial infarction mortality in patients ≥65 years of age: findings from the cooperative cardiovascular project. J Am Coll Cardiol. 2001; 38:1654-61.
20. Cannon CP, McCabe CH, Wilcox RG, Bentley JH, Braunwald E. Association of white blood cell count with increased mortality in acute myocardial infarction and unstable angina pectoris. OPUS-TIMI 16 Investigators. Am J Cardiol. 2001;87:636-9.
21. Sabatine MS, Morrow DA, Cannon CP, Murphy SA, Demopoulos LA, DiBattiste PM, et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis in Myocardial Infarction 18 trial) substudy. J Am Coll Cardiol. 2002;40: 1761-8.
22. Yen MH, Bhatt DL, Chew DP, Harrington RA, Newby LK, Ardissino D, et al. Association between admission white blood cell count and one-year mortality in patients with acute coronary syndromes. Am J Med. 2003;115:318-21.
23. Menon V, Lessard D, Yarzebski J, Furman MI, Gore JM, Goldberg RJ. Leukocytosis and adverse hospital outcomes after acute myocardial infarction. Am J Cardiol. 2003;92:368-72.
24. Bhatt DL, Chew DP, Lincoff AM, Simoons ML, Harrington RA, Ommen SR, et al. Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes. Am J Cardiol. 2003;92:136-40.
25. Mueller C, Neumann FJ, Perruchoud AP, Buettner HJ. White blood cell count and long term mortality after non-ST elevation acute coronary syndrome treated with very early revascularisation. Heart. 2003;89:389-92.
26. Kyne L, Hausdorff JM, Knight E, Dukas L, Azhar G, Wei JY. Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J. 2000;139:94-100.
27. Furman MI, Gore JM, Anderson FA, Budaj A, Goodman SG, Avezum A, et al. Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2004;147:42-8.
28. Hung MJ, Cherng WJ. Comparison of white blood cell counts in acute myocardial infarction patients with significant versus insignificant coronary artery disease. Am J Cardiol. 2003;91:1339-42.
29. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000;21:1502-13.
30. Cannon CP, Battler A, Brindis RG, Cox JL, Ellis SG, Every NR, et al. American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee). J Am Coll Cardiol. 2001;38:2114-30.
31. Arós F, Loma-Osorio A, Alonso A, Alonso JJ, Cabadés A, Coma-Canella I, et al. Guías de actuación clínica de la Sociedad Española de Cardiología an el infarto agudo de miocardio. Rev Esp Cardiol. 1999;52:919-56.
32. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999;28:964-74.
33. Wong CK, French JK, Gao W, White HD. Relationship between initial white blood cell counts, stage of acute myocardial infarction evolution at presentation, and incidence of Thrombolysis In Myocardial Infarction-3 flow after streptokinase. Am Heart J. 2003;145:95-102.
34. Neumann FJ, Zohlnhofer D, Fakhoury L, Ott I, Gawaz M, Schomig A. Effect of glycoprotoin IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol. 1999;34:1420-6.
35. Engler RL, Dahlgren MD, Morris DD, Peterson MA, Schmid-Schonbein GW. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol. 1986;251:H314-23.
36. Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A, et al. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation. 1999;99:1492-8.
37. Cotter G, Kaluski E, Milo O, Blatt A, Salah A, Hendler A, et al. LINCS: L-NAME (a NO synthase inhibitor) in the treatment of refractory cardiogenic shock: a prospective randomized study. Eur Heart J. 2003;24:1287-95.
38. Lucchesi BR. Modulation of leukocyte-mediated myocardial reperfusion injury. Annu Rev Physiol. 1990;52:561-76.
39. Chatelain P, Latour JG, Tran D, De Lorgeril M, Dupras G, Bourassa M. Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion. Circulation. 1987;75:1083-90.
40. Jolly SR, Kane WJ, Hook BG, Abrams GD, Kunkel SL, Lucchesi BR. Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion. Am Heart J. 1986;112:682-90.
41. Romson JL, Hook BG, Kunkel SL, Abrams GD, Schork MA, Lucchesi BR. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 1983;67: 1016-23.